Epilepsy Partnerships Neurelis' focus on VALTOCO and active participation in epilepsy events signals readiness to expand patient access. Target opportunities include partnering with hospital systems, epilepsy centers, and payer programs to broaden formulary coverage and co-branded patient education. Identify decision-makers such as Chief Medical Officer, Head of Neurology, and payer account directors to initiate outreach.

Pipeline Collaboration With NRL-1049 in development and leadership expansion, there may be demand for clinical development and regulatory support. Offer CRO, regulatory affairs, and contract manufacturing services, and connect with neurology-focused trial sites and contract research networks to support pipeline progression.

Marketing Enablement Neurelis has demonstrated marketing leadership through a major award for VALTOCO campaigns. There is opportunity to collaborate on advanced digital marketing, multichannel patient engagement, and compliant privacy-ready marketing tech, plus regional asset localization to support broader adoption.

Manufacturing Partnerships As a mid-sized pharma with a scalable product pipeline, Neurelis could benefit from additional manufacturing, packaging, and distribution capabilities. Propose becoming a preferred contract manufacturing or fill-finish partner for nasal spray products, and explore logistic partnerships for national distribution.

Event Driven Outreach Regular epilepsy-focused events create fertile ground for lead generation. Propose sponsorships, exhibit opportunities, and speaker slots to build relationships with neurology clinicians, epilepsy centers, and patient groups; capture leads for product and pipeline opportunities and align with marketing and medical affairs.